Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice

被引：0
|
作者：
Shiwei Lv
Ruixin Fan
Yanping Du
Mengjun Hou
Zhihong Tang
Wenhua Ling
Huilian Zhu
机构：
[1] Sun Yat-Sen University,Faculty of Nutrition, School of Public Health
[2] The Fifth People’s Hospital of Zhengzhou,The Sixth Affiliated Hospital (Gastrointestinal and Anal Hospital)
[3] Sun Yat-Sen University,undefined
来源：
European Journal of Nutrition | 2009年 / 48卷
关键词：
Betaine; Atherosclerosis; Inflammation; Lipids; DNA methylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：205 / 212
页数：7
相关论文
共 50 条
  • [41] Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice
    Chengmin Huang
    Peng Zhang
    Tingting Li
    Jun Li
    Tianjiao Liu
    Anju Zuo
    Jiying Chen
    Yuan Guo
    Molecular and Cellular Biochemistry, 2019, 455 : 99 - 108
  • [42] Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice
    Huang, Chengmin
    Zhang, Peng
    Li, Tingting
    Li, Jun
    Liu, Tianjiao
    Zuo, Anju
    Chen, Jiying
    Guo, Yuan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 455 (1-2) : 99 - 108
  • [43] Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport
    Yi, Peng
    Jin, Xu
    Yi, Zeng
    Long, Chen
    Le, Xu Xiao
    PHYTOMEDICINE, 2019, 62
  • [44] Eplerenone Reduced Lesion Size in Early but Not Advanced Atherosclerosis in Apolipoprotein E-Deficient Mice
    Raz-Pasteur, Ayelet
    Gamliel-Lazarovich, Aviva
    Coleman, Raymond
    Keidar, Shlomo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (06) : 508 - 512
  • [45] Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice
    Xiao-xing Wang
    Xiao-xi Lv
    Jia-ping Wang
    Hui-min Yan
    Zi-yan Wang
    Han-zhi Liu
    Xiao-ming Fu
    Zhuo-wei Hu
    Acta Pharmacologica Sinica, 2013, 34 : 1025 - 1035
  • [46] Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice
    De Beer, Maria C.
    Wroblewski, Joanne M.
    Noffsinger, Victoria P.
    Rateri, Debra L.
    Howatt, Deborah A.
    Balakrishnan, Anju
    Ji, Ailing
    Shridas, Preetha
    Thompson, Joel C.
    van der Westhuyzen, Deneys R.
    Tannock, Lisa R.
    Daugherty, Alan
    Webb, Nancy R.
    De Beer, Frederick C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (02) : 255 - 261
  • [47] Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice
    Wang, Xiao-xing
    Lv, Xiao-xi
    Wang, Jia-ping
    Yan, Hui-min
    Wang, Zi-yan
    Liu, Han-zhi
    Fu, Xiao-ming
    Hu, Zhuo-wei
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (08) : 1025 - 1035
  • [48] Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions
    Fransen, Paul
    Van Assche, Tim
    Guns, Pieter-Jan
    Van Hove, Cor E.
    De Keulenaer, Gilles W.
    Herman, Arnold G.
    Bult, Hidde
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2008, 455 (05): : 811 - 818
  • [49] Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
    Hanniman, EA
    Lambert, G
    McCarthy, TC
    Sinal, CJ
    JOURNAL OF LIPID RESEARCH, 2005, 46 (12) : 2595 - 2604
  • [50] Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient mice
    Hayek, T
    Hamoud, S
    Keidar, S
    Pavlotzky, E
    Coleman, R
    Aviram, M
    Kaplan, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 43 (01) : 140 - 147
12345